DiscoverSquawk PodAstraZeneca in the Vaccine Race; Ballots in Georgia
AstraZeneca in the Vaccine Race; Ballots in Georgia

AstraZeneca in the Vaccine Race; Ballots in Georgia

Update: 2020-11-23
Share

Description

AstraZeneca’s Covid vaccine is the third one to prove highly effective in late-stage trials. AstraZeneca Executive Vice President Ruud Dobber explains differentiators of his company’s vaccine, and why between his company, Pfizer, and Moderna, he has high hopes for an accessible vaccine. New York Times columnist Thomas Friedman discusses the next steps in the race for a vaccine and in the Presidential transition. Plus, political pollster and strategist Frank Luntz unpacks what’s at stake on the ballots in Georgia. 

Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

AstraZeneca in the Vaccine Race; Ballots in Georgia

AstraZeneca in the Vaccine Race; Ballots in Georgia

CNBC